Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?

Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?

Chronic kidney disease has become a major medical issue in recent years due to its high prevalence worldwide, its association with premature mortality, and its social and economic implications. A number of patients gradually progress to end-stage renal disease (ESRD), requiring then dialysis and kid...

Full description

Bibliographic Details
Main Authors: Carolina Lavoz, Sandra Rayego-Mateos, Macarena Orejudo, Lucas Opazo-Ríos, Vanessa Marchant, Laura Marquez-Exposito, Antonio Tejera-Muñoz, Juan F. Navarro-González, Alejandra Droguett, Alberto Ortiz, Jesús Egido, Sergio Mezzano, Raúl R. Rodrigues-Diez, Marta Ruiz-Ortega
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Journal of Clinical Medicine
Subjects:
diabetic nephropathy
inflammation
immune cells
cytokines
il-17a
treatment
diabetes mellitus
proteinuria
Online Access:https://www.mdpi.com/2077-0383/9/1/272

Internet

https://www.mdpi.com/2077-0383/9/1/272

Similar Items